Our in silico analysis showed that, together with miR-21-5p, miR-26a-5p and miR-222-3p targeted the PTEN gene, suggesting that the PI3K-AKT insulin signaling pathway should be further explored as a potential therapeutic target for insulin resistance in PCOS. The gene discussed is INS; the disease is Insulin resistance.